News Releases

12.14.2018

SonoMotion receives FDA IDE approval to initiate its Break Wave™ First-In-Human clinical trial in the United States.

10.31.2017

GE Healthcare and SonoMotion establish a strategic partnership and sign a definitive OEM agreement and co-development agreement.

08.01.2017

SonoMotion receives a $1.0M SBIR Commercial Readiness Program grant from the NIH for the development of Stone Clear™.

04.07.2017

SonoMotion closes on a $4.6M Series-A round led by MedVenture Partners Inc. and with a significant participation by Bioventures Investors.

05.01.2016

SonoMotion secures a $1.75M SBIR FastTrack grant from the NIH for the development of Break Wave™.

04.01.2016

SonoMotion receives a $350,000 grant from NASA and NSBRI to accelerate development of Break Wave™.

12.02.2015

SonoMotion wins Runner-Up and $50,000 in the prestigious prime UC life science startup competition organized by the University of California and Johnson & Johnson.

09.07.2015

Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.